• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

News & Events

  • Print
  • Share
  • E-mail

Public Calendar: April 4-8, 2011

This public calendar is issued by the Food and Drug Administration. It lists significant meetings held by designated FDA policy makers with persons outside the executive branch of the Federal Government.

 

April 4-8, 2011
FDA Official and TitleDateLocationOther FDA ParticipantsNon-FDA ParticipantsSubject
Margaret A. Hamburg, M.D., Commissioner of Food and Drugs4/5/11Washington, DCRalph Tyler, Dara Corrigan, Jeff Shuren, Janet Woodcock, Michael Landa, Lawrence Deyton, Bernadette Dunham, Diane Maloney, Tracey ForfaN/A2011 Food and Drug Law Institute Annual Conference
Margaret A. Hamburg, M.D., Commissioner of Food and Drugs4/7/11Washington, DCKanya BalakrishnaN/ASpeech at World Health Day 2011
John M. Taylor, III, J.D., Acting Principal Deputy Commissioner of Food and Drugs4/4/11Washington, DCJeanne IrelandDora Hughes, Noelle Lee, LaWanda Harris, Jarel LaPan, Paul Lipkin (Office of the Secretary, Health and Human Services); Allan Coukell,  Carolyn Brickey (PEW Health Group)Legislation to Improve the Safety of the US Drug Supply
Dara A. Corrigan, Associate Commissioner for Regulatory Affairs4/4/11-4/8/11N/AN/AN/ANo Significant Meetings
Curtis L. Coy, Deputy Commissioner for Administration4/4/11-4/8/11N/AN/AN/ANo Significant Meetings
Lawrence Deyton, M.S.P.H., M.D., Director, Center for Tobacco Products4/4/11-4/8/11N/AN/AN/ANo Significant Meetings
David Dorsey, J.D., Acting Deputy Commissioner for Policy, Planning, and Budget4/7/11Washington, DCN/ASeveral representatives from MerckThe FDA and Federal Regulatory Priorities
David Dorsey, J.D., Acting Deputy Commissioner for Policy, Planning, and Budget4/9/11Boston, MA (via videoconference)Ronald RabinVarious participants from universities/medical schools, NIH, IOM, Genentech, DynaVAX, Greer LaboratoriesThe FDA and Federal Regulatory Priorities
Bernadette Dunham, D.V.M., Ph.D., Director, Center for Veterinary Medicine4/4/11-4/8/11N/AN/AN/ANo Significant Meetings
Jesse Goodman, M.D., M.P.H., Chief Scientist and Deputy Commissioner for Science and Public Health4/4/11-4/8/11N/AN/AN/ANo Significant Meetings
Michael M. Landa, Acting Director, Center for Food Safety and Applied Nutrition4/7/11College Park, MDBarbara Schneeman, Mary Poos, Nancy Yanish, Jill Kevela, Shirley Blakely, Blakeley Fitzpatrick, Claudine Kavanaugh, Jason August, Jordan Lin, Paula Trumbo, Jessica Leighton, Gloria OverholserBonnie Lieberman (Center for Science in the Public Interest); Suzzane Murphy (University of Hawaii);  Allison Yates, Beth Yetley, John Vanderveen, Virginia Wilkening (Former CFSAN Employees) Estimated Average Requirements and Recommended Daily Allowances 
Murray M. Lumpkin, M.D., Deputy Commissioner for International Programs4/6/11Washington, DCRobert WestJavier Amtmann (Laboratorio Sanfer); Antonio Lopez de Silanes, Guillermo Funes, Ivo Stern (Laboratorio Silanes); Alfredo Rimoch (Laboratorio Liomont); Carlos Senosiain (Laboratorio Senosiain); Fernando Espinosa (Laboratorio Rimsa); Eric Hagsater (Laboratorio Chinoin); Dagoberto Cortes (Laboratorio Hormona); Ernesto Enriquez (former Commissioner, COFEPRIS); Gemi Jose Gonzalez (Gobernanza Consultores); M Fabiana Jorge, Colette Walker (MFJ International)Regulatory Aspects of the US Generic Market
Beth Martino, Associate Commissioner for External Affairs4/4/11-4/8/11N/AN/AN/ANo Significant Meetings
Karen Midthun, M.D., Director, Center for Biologics Evaluation and Research4/4/11-4/8/11N/AN/AN/ANo Significant Meetings  
Jeffrey Shuren, M.D., J.D., Director, Center for Devices and Radiological Health4/6/11Silver Spring, MDSeveral FDA officials and staff membersSeveral representatives from Quintiles InternationalMedical Devices
Jeffrey Shuren, M.D., J.D., Director, Center for Devices and Radiological Health4/8/11Silver Spring, MDN/ASeveral representatives from AdvaMedMedical Devices
William Slikker, Jr., Ph.D., Director, National Center for Toxicological Research4/8/11Morrilton, ARN/AN/APresentation at the Arkansas Nanotechnology and Health Care Conference
Michael R. Taylor, J.D., Deputy Commissioner for Foods, Office of Foods4/8/11Silver Spring, MDJeanne IrelandScott Faber (Grocery Manufacturers Association); Joe Levitt (Hogan & Hartson)Food Safety Implementation
Ralph Tyler, J.D., Chief Counsel4/4/11-4/8/11N/AN/AN/ANo Significant Meetings
Jill Hartzler Warner, J.D., Acting Associate Commissioner for Special Medical Programs4/4/11-4/8/11N/AN/AN/ANo Significant Meetings
Janet Woodcock, M.D., Director, Center for Drug Evaluation and Research4/6/11Philadelphia, PAN/AEd Fotsch (PDR Network); Kevin Fickenscher (Dell Healthcare Services); Thomas Menighan (American Pharmacists Association); Glen Tullman (Allscripts)The First Annual PharmEHR Summit